MMP1 and invasive breast carcinoma: High MMP-1 gene expression has also been reported to predict for a lower overall survival rate in invasive breast carcinoma [68] and poorer prognosis in patients treated with systemic therapy [69,70]; thus, the expression of MMP-1 is a significant prognostic indicator and a potential drug target for BC [70].